{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:36Z","timestamp":1790371056138,"version":"4.1.0"},"reference-count":24,"publisher":"Baskent University","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.6002\/ect.2021.0433","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T02:50:51Z","timestamp":1642474251000},"page":"757-761","source":"Crossref","is-referenced-by-count":3,"title":["Role of Cytomegalovirus in the Development of Posttransplant Lymphoproliferative Disorders With or Without Epstein-Barr Virus Infection"],"prefix":"10.6002","volume":"20","author":[{"given":"Mandana","family":"Namayandeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Jamalidoust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Pouladfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazyar","family":"Ziyaeyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4021","reference":[{"key":"ref0","unstructured":"References"},{"key":"ref1","unstructured":"1. United Network for Organ Sharing. Organ transplant. 2021. https:\/\/unos.org\/transplant"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"2. Razonable RR, Zerr DM; AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant. 2009;9 Suppl 4:S97-100. doi:10.1111\/j.1600-6143.2009.02899_1.x","DOI":"10.1111\/j.1600-6143.2009.02899_1.x"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"3. Sampaio AM, Guardia AC, Milan A, et al. Co-infection and clinical impact of human herpesvirus 5 and 6 in liver transplantation. Transplant Proc. 2012;44(8):2455-2458. doi:10.1016\/j.transproceed.2012.07.034","DOI":"10.1016\/j.transproceed.2012.07.034"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"4. Cho YU, Chi HS, Jang S, Park SH, Park CJ. Pattern analysis of Epstein-Barr virus viremia and its significance in the evaluation of organ transplant patients suspected of having posttransplant lymphoproliferative disorders. Am J Clin Pathol. 2014;141(2):268-274. doi:10.1309\/AJCP9WYEXKOL9YUV","DOI":"10.1309\/AJCP9WYEXKOL9YUV"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"5. Jamalidoust M, Geramizadeh B, Pouladfar G, et al. Epstein-Barr virus DNAemia in Iranian liver transplant recipients and assessment of its variation in posttransplant lymphoproliferative disorder patients by quantitative polymerase chain reaction assay. Exp Clin Transplant. 2015;13 Suppl 1:306-311. doi:10.6002\/ect.mesot2014.p148","DOI":"10.6002\/ect.mesot2014.P148"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"6. Verghese PS, Schmeling DO, Knight JA, Matas AJ, Balfour HH, Jr. The impact of donor viral replication at transplant on recipient infections posttransplant: a prospective study. Transplantation. 2015;99(3):602-608. doi:10.1097\/TP.0000000000000354","DOI":"10.1097\/TP.0000000000000354"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"7. Razonable RR, Brown RA, Humar A, et al. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis. 2005;192(8):1331-1339. doi:10.1086\/466529","DOI":"10.1086\/466529"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"8. Petrara MR, Giunco S, Serraino D, Dolcetti R, De Rossi A. Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment. Cancer Lett. 2015;369(1):37-44. doi:10.1016\/j.canlet.2015.08.007","DOI":"10.1016\/j.canlet.2015.08.007"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"9. Opelz G, Daniel V, Naujokat C, Fickenscher H, Dohler B. Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis. Lancet Oncol. 2007;8(3):212-218. doi:10.1016\/S1470-2045(07)70040-2","DOI":"10.1016\/S1470-2045(07)70040-2"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"10. Jamalidoust M, Namayandeh M, Asaei S, Aliabadi N, Ziyaeyan M. Determining hepatitis C virus genotype distribution among high-risk groups in Iran using real-time PCR. World J Gastroenterol. 2014;20(19):5897-5902. doi:10.3748\/wjg.v20.i19.5897","DOI":"10.3748\/wjg.v20.i19.5897"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"11. Jaksch P, Wiedemann D, Kocher A, Murakozy G, Augustin V, Klepetko W. Effect of cytomegalovirus immunoglobulin on the incidence of lymphoproliferative disease after lung transplantation: single-center experience with 1157 patients. Transplantation. 2013;95(5):766-772. doi:10.1097\/TP.0b013e31827df7a7","DOI":"10.1097\/TP.0b013e31827df7a7"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"12. Manez R, Breinig MC, Linden P, et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis. 1997;176(6):1462-1467. doi:10.1086\/514142","DOI":"10.1086\/514142"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"13. Arcenas R, Widen RH. Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus. BMC Microbiol. 2002;2:20. doi:10.1186\/1471-2180-2-20","DOI":"10.1186\/1471-2180-2-20"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"14. Preiksaitis JK, Keay S. Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients. Clin Infect Dis. 2001;33 Suppl 1:S38-46. doi:10.1086\/320903","DOI":"10.1086\/320903"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"15. Singh N. Interactions between viruses in transplant recipients. Clin Infect Dis. 2005;40(3):430-436. doi:10.1086\/427214","DOI":"10.1086\/427214"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"16. Pocock JM, Storisteanu DML, Reeves MB, et al. Human cytomegalovirus delays neutrophil apoptosis and stimulates the release of a prosurvival secretome. Front Immunol. 2017;8:1185. doi:10.3389\/fimmu.2017.01185","DOI":"10.3389\/fimmu.2017.01185"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"17. Costa H, Nascimento R, Sinclair J, Parkhouse RM. Human cytomegalovirus gene UL76 induces IL-8 expression through activation of the DNA damage response. PLoS Pathog. 2013;9(9):e1003609. doi:10.1371\/journal.ppat.1003609","DOI":"10.1371\/journal.ppat.1003609"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"18. Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735-6741. doi:10.1158\/1078-0432.CCR-07-4843","DOI":"10.1158\/1078-0432.CCR-07-4843"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"19. Hancock MH, Hook LM, Mitchell J, Nelson JA. Human cytomegalovirus microRNAs miR-US5-1 and miR-UL112-3p block proinflammatory cytokine production in response to NF-kappaB-activating factors through direct downregulation of IKKalpha and IKKbeta. mBio. 2017;8(2). doi:10.1128\/mBio.00109-17","DOI":"10.1128\/mBio.00109-17"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"20. Mathers C, Schafer X, Mart\u00ednez-Sobrido L, Munger J. The human cytomegalovirus UL26 protein antagonizes NF-\u03baB activation. J Virol. 2014;88(24):14289-14300. doi:10.1128\/JVI.02552-14","DOI":"10.1128\/JVI.02552-14"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"21. DeMeritt IB, Milford LE, Yurochko AD. Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter. J Virol. 2004;78(9):4498-4507. doi:10.1128\/jvi.78.9.4498-4507.2004","DOI":"10.1128\/JVI.78.9.4498-4507.2004"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"22. Kim JM, Lee SK, Kim SJ, et al. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia. Transplant Proc. 2010;42(3):895-899. doi:10.1016\/j.transproceed.2010.02.042","DOI":"10.1016\/j.transproceed.2010.02.042"},{"key":"ref23","unstructured":""}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T04:38:21Z","timestamp":1662007101000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ectrx.org\/detail\/archive\/2022\/20\/8\/0\/757\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2021.0433","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}